Ulla Olsson-Strömberg
Läkare vid Institutionen för medicinska vetenskaper; Hematologi
- Mobiltelefon:
- 070-952 26 67
- E-post:
- Ulla.Olsson-Stromberg@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ing 101, plan 4
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ing 100, plan 2
751 85 Uppsala
Publikationer
Senaste publikationer
Ingår i Leukemia, s. 1722-1730, 2024
Ingår i Leukemia, s. 1072-1080, 2024
- DOI för Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
- Ladda ner fulltext (pdf) av Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
Ingår i Journal of Clinical Oncology, 2024
Ingår i Leukemia, s. 109-125, 2024
- DOI för Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
- Ladda ner fulltext (pdf) av Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
Ingår i Leukemia, s. 1156-1159, 2023
- DOI för The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
- Ladda ner fulltext (pdf) av The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
Alla publikationer
Artiklar i tidskrift
Ingår i Leukemia, s. 1722-1730, 2024
Ingår i Leukemia, s. 1072-1080, 2024
- DOI för Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
- Ladda ner fulltext (pdf) av Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
Ingår i Journal of Clinical Oncology, 2024
Ingår i Leukemia, s. 109-125, 2024
- DOI för Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
- Ladda ner fulltext (pdf) av Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation
Ingår i Leukemia, s. 1156-1159, 2023
- DOI för The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
- Ladda ner fulltext (pdf) av The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study
Ingår i Blood, s. 73-89, 2023
- DOI för Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
- Ladda ner fulltext (pdf) av Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
Ingår i Annals of Hematology, s. 1395-1408, 2023
Ingår i Lipids in Health and Disease, 2023
- DOI för Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
- Ladda ner fulltext (pdf) av Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening
Ingår i Cancer Informatics, s. 1-8, 2022
- DOI för Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening
- Ladda ner fulltext (pdf) av Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening
Ingår i American Journal of Hematology, s. 421-430, 2022
- DOI för Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study
- Ladda ner fulltext (pdf) av Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study
Ingår i Journal of Clinical Investigation, 2022
- DOI för IFN-alfa with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
- Ladda ner fulltext (pdf) av IFN-alfa with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
Ingår i European Journal of Haematology, s. 617-623, 2021
- DOI för Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
- Ladda ner fulltext (pdf) av Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
Ingår i British Journal of Haematology, s. 915-921, 2021
- DOI för Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry
- Ladda ner fulltext (pdf) av Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry
Ingår i Leukemia, s. 2416-2418, 2021
- DOI för Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR: final report from AFTER-SKI
- Ladda ner fulltext (pdf) av Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR: final report from AFTER-SKI
Ingår i Leukemia Research, 2020
Ingår i Leukemia, s. 2125-2137, 2020
- DOI för Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
- Ladda ner fulltext (pdf) av Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Ingår i Biology of blood and marrow transplantation, s. 50-57, 2020
Ingår i Bone Marrow Transplantation, s. 1764-1774, 2019
Ingår i Oncoimmunology, 2019
- DOI för Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
- Ladda ner fulltext (pdf) av Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
Ingår i American Journal of Hematology, s. 1236-1243, 2019
- DOI för Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
- Ladda ner fulltext (pdf) av Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
Ingår i The Lancet Oncology, s. 747-757, 2018
Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
Ingår i Scientific Reports, s. 1-9, 2017
- DOI för Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
- Ladda ner fulltext (pdf) av Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia
Ingår i PLOS ONE, 2017
- DOI för Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
- Ladda ner fulltext (pdf) av Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
Ingår i Journal of Cancer Research and Clinical Oncology, s. 1543-1554, 2017
KIT signaling is dispensable for human mast cell progenitor development
Ingår i Blood, s. 1785-1794, 2017
Ingår i Haematologica, s. 153-153, 2017
Ingår i Haematologica, s. 435-435, 2017
Ingår i Leukemia, s. 1108-1116, 2017
- DOI för Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
- Ladda ner fulltext (pdf) av Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
Ingår i European Journal of Haematology, s. 57-66, 2017
Ingår i Leukemia, s. 1825-1827, 2017
Ingår i Biochemical and Biophysical Research Communications - BBRC, s. 378-384, 2017
- DOI för Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34 (+)CD38(-) stem and progenitor cells in chronic myeloid leukemia
- Ladda ner fulltext (pdf) av Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34 (+)CD38(-) stem and progenitor cells in chronic myeloid leukemia
Ingår i Nature Medicine, s. 692-+, 2017
Ingår i Blood, s. 2384-2394, 2017
Ingår i Leukemia Research, s. 95-103, 2016
Ingår i Haematologica, s. 730-730, 2016
Ingår i Therapeutic Drug Monitoring, s. 230-238, 2016
Ingår i European Journal of Haematology, s. 387-392, 2016
Ingår i Leukemia, s. 1853-1860, 2016
Ingår i Haematologica, s. 457-458, 2016
Assessment Of Therapy Response In Chronic Myeloid Leukemia Via 1 Month Bcr-Abl1 Transcript Decline
Ingår i Haematologica, s. 63-63, 2016
Ingår i Haematologica, s. 22-23, 2016
Ingår i Leukemia, s. 1562-1567, 2016
Ingår i Journal of Cancer Research and Clinical Oncology, s. 1041-1050, 2016
Ingår i Annals of Internal Medicine, s. 161-166, 2016
Ingår i BMC Cancer, 2015
- DOI för Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
- Ladda ner fulltext (pdf) av Clonal distribution of BCR-ABL1 mutations and splice isoforms by single-molecule long-read RNA sequencing
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
Ingår i PLOS ONE, 2015
- DOI för Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
- Ladda ner fulltext (pdf) av Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
Ingår i Molecular Cancer Therapeutics, s. 1181-1191, 2015
Ingår i European Journal of Haematology, s. 243-250, 2015
- DOI för Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
- Ladda ner fulltext (pdf) av Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
Ingår i British Journal of Haematology, s. 683-688, 2015
FLOW CYTOMETRY-BASED ASSAY FOR DETECTION OF BCR-ABL FUSION PROTEIN IN BLOOD CELLS FROM CML PATIENTS
Ingår i Haematologica, s. 694-695, 2015
Ingår i Haematologica, s. 233-233, 2015
Ingår i Blood, 2015
Ingår i Blood, 2015
Ingår i Blood, 2015
Ingår i Blood, 2015
Ingår i Blood, 2015
Ingår i Blood, 2015
The use of multiplex platforms for absolute and relative protein quantification of clinical material
Ingår i EuPA Open Proteomics, s. 37-47, 2014
Ingår i Molecular Therapy, 2014
Ingår i Scandinavian Journal of Immunology, s. 467-468, 2014
CAR T Cells Express CD40L and Activates Human Dendritic Cells
Ingår i Molecular Therapy, 2014
Ingår i Journal of Clinical Oncology, s. 2821-2823, 2014
Ingår i Blood, 2014
Ingår i Blood, 2014
Ingår i Blood, 2014
Ingår i PLOS ONE, 2013
- DOI för Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
- Ladda ner fulltext (pdf) av Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Enhanced proliferation and tyrosine kinase pathway engagement in 4-1BB domain-containing CAR T cells
Ingår i Human Gene Therapy, 2013
Ingår i Blood, s. 1284-1292, 2013
Ingår i Leukemia, s. 1520-1526, 2013
Ingår i Blood, s. 3228-3235, 2011
Ingår i Immunology, s. 371-376, 2010
Ingår i European Journal of Haematology, s. 399-404, 2010
Ingår i The Hematology Journal, s. 462-466, 2004